• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493952838250
Medical Device Problem Code Bent (1059)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event or Problem Description
It was reported that stent damage occurred.The target lesion was located in a coronary artery.A 2.50x38mm promus premier¿ drug-eluting stent was selected for use but was noted to be damaged.The procedure was completed with another of the same device.No patient complications nor adverse conditions were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: promus premier us, mr, 2.5x38mm, stent delivery system (sds) was returned for analysis.A visual examination of the crimped stent found no issues with the crimped stent.There were no signs of damage; stretching or lifting of the stent struts.The stent od (outer diameter) measured and was within the maximum crimped stent specification.The balloon cones were reviewed and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and tactile examination found no issue with the hypotube.A visual and tactile examination found no issue with the extrusion.The bi-component bond showed no signs of damage or strain.A visual and tactile examination found no damage to the tip.The root cause is not confirmed as there was no evidence of the alleged issue or any anomalies which could have contributed to the reported difficulty.(b)(4).
 
Event or Problem Description
It was reported that stent damage occurred.The target lesion was located in a coronary artery.A 2.50x38mm promus premier¿ drug-eluting stent was selected for use but was noted to be damaged.The procedure was completed with another of the same device.No patient complications nor adverse conditions were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER¿
Common Device Name
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key6912292
Report Number2134265-2017-09738
Device Sequence Number19010551
Product Code NIQ
UDI-Device Identifier08714729845003
UDI-Public08714729845003
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
P110010
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 09/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/02/2018
Device Model NumberH7493952838250
Device Catalogue Number39528-3825
Device Lot Number0019948525
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/29/2017
Initial Date Received by Manufacturer 09/15/2017
Supplement Date Received by Manufacturer10/19/2017
Initial Report FDA Received Date10/03/2017
Supplement Report FDA Received Date11/01/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-